NEW YORK Warner Chilcott has “grade A” revenues for 2007.
Specialty pharmaceutical company said Friday it expects revenue in 2007 to hit the high end of its forecast.
The company previously forecast revenue between $870 million and $890 million. It also expects adjusted profit to range from $1.03 to $1.05 per share. This, the company said, excludes paying back and write-off of deferred loan costs related to debt.
Analysts polled by Thomson Financial expect full-year profit of $1.02 per share on revenue of $883.7 million.
The company estimated selling, general and administration expenses at $262 million to $271 million, with higher legal costs. Research and development expenses are expected to range from $54 million to $57 million.